Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,909,034
-
Share change
-
+1,183,147
-
Total reported value
-
$846,840,446
-
Put/Call ratio
-
150%
-
Price per share
-
$28.31
-
Number of holders
-
107
-
Value change
-
+$33,969,149
-
Number of buys
-
38
-
Number of sells
-
53
Institutional Holders of GENOMIC HEALTH INC - COM (GHDX) as of Q3 2014
As of 30 Sep 2014,
GENOMIC HEALTH INC - COM (GHDX) was held by
107 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,909,034 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Camber Capital Management LLC, BAILLIE GIFFORD & CO, NORTH TIDE CAPITAL, LLC, FMR LLC, Champlain Investment Partners, LLC, VANGUARD GROUP INC, TPG Group Holdings (SBS) Advisors, Inc., BlackRock Fund Advisors, and State Street Corp.
This page lists
107
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.